These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37467819)

  • 1. An evaluation of microcrystalline cellulose attributes affecting compaction-induced pellet coat damage through a multi-faceted analysis.
    Thio DR; Aguilera Q; Yeoh JKX; Sia Heng PW; Chan LW
    Int J Pharm; 2023 Aug; 643():123245. PubMed ID: 37467819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and process strategies to minimize coat damage for compaction of coated pellets in a rotary tablet press: A mechanistic view.
    Xu M; Heng PWS; Liew CV
    Int J Pharm; 2016 Feb; 499(1-2):29-37. PubMed ID: 26748363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic understanding of compression damage to the dissolubility of coated pellets in tablets.
    Hiew TN; Tian YH; Tan HM; Heng PWS
    Eur J Pharm Biopharm; 2020 Jan; 146():93-100. PubMed ID: 31786321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the porosity of cushioning excipients on the compaction of coated multi-particulates.
    Elsergany RN; Chan LW; Heng PWS
    Eur J Pharm Biopharm; 2020 Jul; 152():218-228. PubMed ID: 32445966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUPS Tableting-Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets.
    Thio DR; Heng PWS; Chan LW
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushioning pellets based on microcrystalline cellulose - Crospovidone blends for MUPS tableting.
    Elsergany RN; Chan LW; Heng PWS
    Int J Pharm; 2020 Aug; 586():119573. PubMed ID: 32599135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tableting of coated multiparticulates: Influences of punch face configurations.
    Thio DR; Veronica N; Heng PWS; Chan LW
    Int J Pharm; 2024 Mar; 653():123863. PubMed ID: 38307400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanistic investigation on the utilization of lactose as a protective agent for multi-unit pellet systems.
    Chin WC; Chan LW; Heng PW
    Pharm Dev Technol; 2016 Mar; 21(2):222-30. PubMed ID: 25519982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of potential novel cushioning agents for the compaction of coated multi-particulates by co-processing micronized lactose with polymers.
    Lin X; Chyi CW; Ruan KF; Feng Y; Heng PW
    Eur J Pharm Biopharm; 2011 Oct; 79(2):406-15. PubMed ID: 21458566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of co-spray dried cushioning agent containing stearic acid for protecting pellet coatings when compressed.
    Li X; Xu DS; Li M; Liu L; Heng P
    Drug Dev Ind Pharm; 2016; 42(5):788-95. PubMed ID: 26289006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients.
    Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp J
    Pharm Dev Technol; 2019 Feb; 24(2):145-156. PubMed ID: 29394129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of starting material particle size on pellet surface roughness.
    Sarkar S; Ang BH; Liew CV
    AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulk Freeze-Drying Milling: a Versatile Method of Developing Highly Porous Cushioning Excipients for Compacted Multiple-Unit Pellet Systems (MUPS).
    Siow CRS; Heng PWS; Chan LW
    AAPS PharmSciTech; 2018 Feb; 19(2):845-857. PubMed ID: 29019116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multispectral UV imaging for surface analysis of MUPS tablets with special focus on the pellet distribution.
    Novikova A; Carstensen JM; Rades T; Leopold PDCS
    Int J Pharm; 2016 Dec; 515(1-2):374-383. PubMed ID: 27702695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-destructive method for quality control of the pellet distribution within a MUPS tablet by terahertz pulsed imaging.
    Novikova A; Markl D; Zeitler JA; Rades T; Leopold CS
    Eur J Pharm Sci; 2018 Jan; 111():549-555. PubMed ID: 29056403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Shielding Effect of Microcrystalline Cellulose on Drug Nanocrystal Particles During Compaction.
    Liu Y; Xiao H; Xie J; Zhang Z; Ma Y; Yue P; Yang M
    AAPS PharmSciTech; 2018 Aug; 19(6):2488-2498. PubMed ID: 29948978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.